MARKET

AKRX

AKRX

Akorn
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.190
-0.130
-3.01%
Closed 19:26 11/12 EST
OPEN
4.260
PREV CLOSE
4.320
HIGH
4.360
LOW
4.180
VOLUME
927.97K
TURNOVER
--
52 WEEK HIGH
7.25
52 WEEK LOW
2.340
MARKET CAP
528.55M
P/E (TTM)
-1.4440
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AKRX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 8 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

AKRX News

  • The Zacks Analyst Blog Highlights: Forterra, Barrett Business, Chuy's, Akorn and Quanex
  • Zacks.21h ago
  • 5 Small-Cap Stocks Outpacing the Broader Market in 2019
  • Zacks.1d ago
  • New Strong Buy Stocks for November 7th
  • Zacks.5d ago
  • Akorn to Present at the Credit Suisse Healthcare Conference
  • GlobeNewswire.11/06 00:00

More

Industry

Pharmaceuticals
+0.28%
Pharmaceuticals & Medical Research
+0.31%

Hot Stocks

Name
Price
%Change

About AKRX

Akorn Inc. (Akorn), together with its subsidiaries, is a specialty generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as private-label over-the-counter (OTC) consumer health products and animal health pharmaceuticals. The Company operates through two segments: Prescription Pharmaceuticals and the Consumer Health. The Prescription Pharmaceuticals segment consists of generic and branded prescription pharmaceuticals in a range of dosage forms, including sterile ophthalmics, injectables and inhalants and non-sterile oral liquids, topicals and nasal sprays and otics. The Consumer Health segment consists of branded and private-label OTC products and animal health products dispensed by veterinary professionals. Its branded and private-label OTC products are focused on ophthalmics, including a dry eye treatment TheraTears Therapy for Your Eyes.
More

Webull offers Akorn, Inc. (AKRX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.